{"id":"xingnaojing-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The injection contains active compounds derived from traditional Chinese herbs that work synergistically to improve microcirculation in the brain, reduce inflammation, and provide neuroprotective effects. It is believed to enhance cerebral metabolism and oxygen utilization while reducing ischemic damage in acute stroke and related cerebrovascular conditions.","oneSentence":"Xingnaojing injection is a traditional Chinese medicine formulation that enhances cerebral blood flow and protects neural tissue through multiple bioactive components.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:16:19.399Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke"},{"name":"Cerebral infarction"},{"name":"Post-stroke recovery and rehabilitation"}]},"trialDetails":[{"nctId":"NCT06927336","phase":"PHASE4","title":"The Study on the Efficacy of tDCS Stimulation of the Cerebellum Combined With XingNaoJing Injection in Patients With Consciousness Disorders After Cranial Injury","status":"NOT_YET_RECRUITING","sponsor":"The Second Affiliated Hospital of Kunming Medical University","startDate":"2025-04-25","conditions":"tDCS, Cerebellum, Brain Injury","enrollment":200},{"nctId":"NCT05559307","phase":"PHASE4","title":"Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Ying Gao","startDate":"2022-08-16","conditions":"Ischemic Stroke, Acute","enrollment":20},{"nctId":"NCT04813445","phase":"NA","title":"Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2021-05-28","conditions":"Acute Stroke, Ischemic Stroke","enrollment":72},{"nctId":"NCT04946474","phase":"PHASE4","title":"Clinical Evaluation of the Combination of Symptoms and Symptoms With General Treatment for Acute Hemorrhagic Stroke","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2019-06-01","conditions":"Acute Hemorrhagic Stroke","enrollment":520},{"nctId":"NCT04150835","phase":"PHASE4","title":"Xingnaojing for Mild-to-severe Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2020-03-19","conditions":"Acute Ischemic Stroke, Stroke, Acute, Stroke, Ischemic","enrollment":1200},{"nctId":"NCT04275349","phase":"","title":"Trial of pRehospital Intervention With trAditional Chinese Medicine for Acute strokE","status":"UNKNOWN","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2020-03-20","conditions":"Stroke, Acute Ischemic Stroke, Acute Intracranial Hemorrhage","enrollment":1000},{"nctId":"NCT02728180","phase":"PHASE4","title":"Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS)","status":"UNKNOWN","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2016-03","conditions":"Acute Ischemic Stroke","enrollment":720},{"nctId":"NCT02367248","phase":"PHASE1, PHASE2","title":"Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage","status":"UNKNOWN","sponsor":"Capital Medical University","startDate":"2015-03","conditions":"Intracerebral Hemorrhage","enrollment":180},{"nctId":"NCT00796380","phase":"PHASE4","title":"Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases","status":"UNKNOWN","sponsor":"Shenzhen Children's Hospital","startDate":"2008-12","conditions":"Convulsive Diseases","enrollment":1}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":55,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Xingnaojing injection","genericName":"Xingnaojing injection","companyName":"Dongzhimen Hospital, Beijing","companyId":"dongzhimen-hospital-beijing","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Xingnaojing injection is a traditional Chinese medicine formulation that enhances cerebral blood flow and protects neural tissue through multiple bioactive components. Used for Acute ischemic stroke, Cerebral infarction, Post-stroke recovery and rehabilitation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}